卫光生物
(002880)
| 流通市值：62.12亿 | | | 总市值：62.12亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 790,899,107.6 | 518,095,318.12 | 225,002,020.97 | 1,203,192,257.65 |
| 营业收入 | 790,899,107.6 | 518,095,318.12 | 225,002,020.97 | 1,203,192,257.65 |
| 二、营业总成本 | 599,161,140.13 | 382,125,542.04 | 175,409,771.72 | 900,123,198.06 |
| 营业成本 | 454,996,009.81 | 293,635,521.83 | 132,492,185.24 | 699,324,831.92 |
| 税金及附加 | 7,152,529.83 | 4,738,271.48 | 2,027,661.09 | 9,596,009.73 |
| 销售费用 | 19,848,696.17 | 11,402,709.71 | 5,122,464.1 | 29,107,358.68 |
| 管理费用 | 66,951,615.46 | 41,363,357.21 | 19,680,123.81 | 92,705,179.26 |
| 研发费用 | 35,629,988.19 | 21,591,044.44 | 11,551,806.32 | 49,052,812.69 |
| 财务费用 | 14,582,300.67 | 9,394,637.37 | 4,535,531.16 | 20,337,005.78 |
| 其中:利息费用 | 15,042,855 | 9,965,736.16 | 4,646,577.63 | 22,754,150.06 |
| 其中:利息收入 | 1,053,231.16 | 1,073,373.77 | 412,186.91 | 2,529,090.62 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | - | -14,050,642.96 |
| 加:投资收益 | 3,152,675.52 | 2,022,539.02 | 1,094,694.43 | 5,395,885.18 |
| 资产处置收益 | - | - | - | 45,819.96 |
| 信用减值损失(新) | -17,055,412.91 | -13,543,662.61 | 343,987.15 | -5,344,625.37 |
| 其他收益 | 6,953,068.26 | 4,175,464.99 | 2,284,038.25 | 7,508,043.11 |
| 四、营业利润 | 184,788,298.34 | 128,624,117.48 | 53,314,969.08 | 296,623,539.51 |
| 加:营业外收入 | 73,604.21 | 28,853.93 | 9,569.25 | 1,099,345.52 |
| 减:营业外支出 | 743,516.53 | 425,063.67 | 294,303.45 | 987,746.12 |
| 五、利润总额 | 184,118,386.02 | 128,227,907.74 | 53,030,234.88 | 296,735,138.91 |
| 减:所得税费用 | 26,300,467.72 | 20,652,808.89 | 9,306,702.26 | 42,778,142.39 |
| 六、净利润 | 157,817,918.3 | 107,575,098.85 | 43,723,532.62 | 253,956,996.52 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 157,817,918.3 | 107,575,098.85 | 43,723,532.62 | 253,956,996.52 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 157,860,537.25 | 107,646,345.47 | 43,768,169.85 | 253,516,220.45 |
| 少数股东损益 | -42,618.95 | -71,246.62 | -44,637.23 | 440,776.07 |
| 扣除非经常损益后的净利润 | 155,455,095.31 | 106,303,706.91 | 42,947,348.1 | 263,514,572.94 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.7 | 0.47 | 0.19 | 1.12 |
| (二)稀释每股收益 | 0.7 | 0.47 | 0.19 | 1.12 |
| 九、综合收益总额 | 157,817,918.3 | 107,575,098.85 | 43,723,532.62 | 253,956,996.52 |
| 归属于母公司股东的综合收益总额 | 157,860,537.25 | 107,646,345.47 | 43,768,169.85 | 253,516,220.45 |
| 归属于少数股东的综合收益总额 | -42,618.95 | -71,246.62 | -44,637.23 | 440,776.07 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-23 | 2025-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |